×
Hero Background

Macrolide Antibiotics Companies

ID: MRFR/Pharma/2956-HCR
200 Pages
Kinjoll Dey
October 2025

Macrolide antibiotics companies are pivotal in the pharmaceutical industry, concentrating on the research, development, and production of antibiotics within the macrolide class. These companies contribute to combating bacterial infections by providing effective and targeted antibiotic treatments, promoting better patient health outcomes.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Macrolide Antibiotics Market Research Report - Forecast Till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Macrolide Antibiotics Market

Macrolide Antibiotics Key Companies

 

Latest Macrolide Antibiotics Companies Update


Pfizer strengthens its macrolide portfolio with the acquisition of Asta Medica move expands Pfizer's access to novel macrolide candidates and reinforces their commitment to antibiotic development.


GSK collaborates with academic institutions on research and development of new macrolides collaborative effort leverages expertise from both parties to accelerate the discovery and development of innovative antibiotics.


Alvogen expands its macrolide offerings through strategic partnerships approach allows them to broaden their market reach and cater to diverse patient needs.


List of Macrolide Antibiotics Key Companies in the Market



  • Merck Sharp & Dohme Corp (U.S.)

  • Pfizer Inc. (U.S.)

  • Neo Química (Brazil)

  • Macrolide Pharmaceuticals (U.S.)

  • Teva Pharmaceutical Industries Ltd. (Israel)

  • Fresenius Kabi USA (U.S.)

  • Sandoz International GmbH (Germany)

  • Gland Pharma Limited (India)

  • Mylan N.V. (U.S.)

  • WOCKHARDT (U.S.)